20th Feb 2007 12:33
Synexus Clinical Research PLC20 February 2007 SYNEXUS CLINICAL RESEARCH PLC (the "Company") GRANT OF OPTIONS On 19 February 2007, options over 250,000 ordinary shares of 10p each in SynexusClinical Research PLC were granted to Alan Boyce, a director of the Company, inaccordance with the Rules of the EMI Scheme and Unapproved Share Option Scheme.The options are exercisable in the period 19 February 2007 to 19 February 2017at a price of 52.5p per share representing a grant value of £131,250 and areAlan Boyce's only interest in the issued share capital of the Company. ENDS This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Synectics